
zzso have for many decades been viewed as ideal molecules for cancer zzso Although promising from the start, it has taken much of more than two decades to reach the level of clinical zzso zzso engineering of zzso that is novel technologies for zzso or zzso zzso zzso has greatly advanced their utility in molecular targeting therapies, and in the past four years some therapeutic zzso zzso for zzso zzso and solid tumors, such as zzso for zzso zzso and zzso for zzso breast cancer, have provided sufficient efficacy and safety to support regulatory approval from the zzso Food and Drug zzso They were subsequently approved by the Japanese Ministry of Health, zzso and Welfare in zzso Many molecular biological and zzso studies have revealed the targeting properties of the host immune system and the biological mechanism of cancer cells for a more specific zzso zzso Many clinical trials of zzso zzso as a single agent, or in combination protocol with current standard chemotherapy or zzso have shown promise in the treatment of specific zzso Furthermore, novel zzso designs and improved understanding of the mode of action of current zzso lend great hope to the future of this therapeutic zzso The accumulating results from many zzso clinical and zzso studies may lead to more individualized therapeutic strategies using these agent directed at specific genetic and zzso zzso 

